Aktieanalys

CLS: Orders from ClearPoint Neuro - Redeye

{newsItem.title}

Redeye Publicerad: 09 Jan 2024 11:53

Clinical Laserthermia

Redeye endorses CLS’ new order of SEK8.1m from ClearPoint Neuro. We also learn that CLS received an order of around SEK2.4m during December 2023. We are positive about today’s news and make some estimate changes and, as a result, reiterate our base case of SEK0.4.

Länk till analysen i sin helhet: https://www.redeye.se/research/969652/cls-orders-from-clearpoint-neuro?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt